Cargando…
Reply to “The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations”
Autores principales: | Matsumura, Tsuyoshi, Iwata, Yuko, Asakura, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096031/ https://www.ncbi.nlm.nih.gov/pubmed/29491287 http://dx.doi.org/10.2169/internalmedicine.0592-17 |
Ejemplares similares
-
The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations
por: Stöllberger, Claudia, et al.
Publicado: (2018) -
A Pilot Study of Tranilast for Cardiomyopathy of Muscular Dystrophy
por: Matsumura, Tsuyoshi, et al.
Publicado: (2017) -
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
por: Matsumura, Tsuyoshi, et al.
Publicado: (2022) -
Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast
por: Takahashi, Chisato, et al.
Publicado: (2023) -
Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy
por: Iwata, Yuko, et al.
Publicado: (2019)